The Simoa® Accelerator Laboratory provides biomarker testing services and custom assay development and offers CLIA-licensed protein biomarker services enabled by Ultrasensitive Simoa® technologies.
Access the highest possible sensitivity through the Simoa® Accelerator Laboratory
Discover a collaborative approach to:
- Custom biopharmaceutical research
- Custom Simoa® biomarker assays
- Clinical sample testing
- Reliable results delivery
Ready to expand the possibilities of biomarker science?
The Simoa® Accelerator Laboratory is a full-service center for biopharmaceutical research. The Accelerator Lab provides exploratory protein biomarker testing services for enhanced pharmacokinetics, pharmacodynamics, efficacy, safety, and target engagement.
Users can take advantage of Quanterix's expertise and full suite of instruments to access custom ultrasensitive biomarker assays, conduct robust clinical sample testing, and enjoy reliable delivery of results. All of this is possible in one streamlined service.
Work with Quanterix's experts to meet your research goals while lowering costs and accelerating your timeline to drug approvals.
Why choose the Simoa® Accelerator Laboratory?
In the full-service center of the Simoa® Accelerator Laboratory, users can access expert advice and rapid development of ultrasensitive custom biomarker assays. Users can also enjoy a guided selection of the best antibody pairs and other biomarker testing services.
Choose between commercially available reagents, custom kits, or specific components built with your own proprietary antibodies.
Image Credit: Quanterix
The assay and defined protocols can be used either in-house or in the Accelerator Lab. Regardless of which option you choose, tailored support is available from an experienced team of Quanterix scientists who are dedicated to sponsored research using Simoa® technologies.
The Accelerator Lab gives individualized attention to each project, helping organizations achieve their R&D goals by taking advantage of:
- Custom assay development from Quanterix Simoa® experts
- Flexible scaling to handle up to thousands of samples
- FullQMSinfrastructure for end-to-end project management
- GLP/CLIA/ISO 15189 best practices compliance
- Longitudinal clinical sample testing
CLIA-Licensed laboratory powered by ultra-sensitive Simoa® HD-X and SP-X technologies. Image Credit: Quanterix
Quantify proteins far lower than the Level of Quantification (LoQ) of conventional analog immunoassays. Image Credit: Quanterix
The largest portfolio of Simoa® instruments enables flexible scaling to handle studies of one plate up to thousands of samples. Image Credit: Quanterix
Full quality-management system infrastructure for end-to-end project management. Image Credit: Quanterix
Sample testing for longitudinal and prospective clinical studies. Image Credit: Quanterix
Custom assay development with the expertise of Quanterix Simoa® scientists. Image Credit: Quanterix
Laboratory performance according to applicable GLP/CLIA/ISO 15189 best practices. Image Credit: Quanterix
Exploratory biomarker analysis for enhanced PD studies. Image Credit: Quanterix
Quantify proteins that are BLOQ in typical immunoassay platforms and access baseline analytes in healthy subjects and disease indicators. Image Credit: Quanterix
Use your proprietary antibodies/reagents or commercially available reagents. Image Credit: Quanterix
Ultrasensitive Simoa® technology serves as a foundation for custom biomarker testing services
The Accelerator Lab is built upon the solid foundation of Simoa® technology. This digital immunoassay technology has revolutionized biomarker detection by allowing researchers to examine critical proteins at ultra-low femtogram levels. The Simoa® digital health solution is contributing to early disease detection and innovative treatment approaches.
A state-of-the-art facility run by world-class scientists
The CLIA-licensed lab leverages groundbreaking Simoa® technology to support global research objectives. Quanterix’s team of experienced scientists offers a vast array of instrument experience and a breadth of knowledge on ultrasensitive assay development. Users can leverage this expertise to get instant access to Simoa® technology and personal guidance through the manufacturing process.
Image Credit: Quanterix
The Accelerator Lab, and Quanterix in particular, are the pioneers in this ultra-sensitive technology to measure not only neurofilament but other biomarkers.
Disarm Therapeutics